A new drug in phase II

A board to discuss future MS therapies in early stage (Phase I or II) trials.

A new drug in phase II

Postby dignan » Fri Jun 23, 2006 10:46 am

I haven't heard of this before, and didn't see it on the company's website.



A Study in Multiple Sclerosis Patients to Determine the Safety of Different Doses of A4I Compared to Placebo and Their Effects on Multiple Sclerosis Lesions

This study is not yet open for patient recruitment.

Verified by Hoffmann-La Roche June 2006
Sponsored by: Hoffmann-La Roche
Information provided by: Hoffmann-La Roche

Purpose
The purpose of this study is to determine the safety and the effects of different doses of an investigational compound A4I compared to placebo. Throughout the study participants will be evaluated by Magnetic Resonance Imaging (MRI) scans to determine the effects of the drug on Multiple Sclerosis lesions.

Drug: A4I
Phase II
Study start: April 2005

http://www.clinicaltrials.gov/ct/show/N ... 3?order=55
User avatar
dignan
Family Elder
 
Posts: 1610
Joined: Wed Aug 11, 2004 3:00 pm

Advertisement

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users